Integer Holdings Corp. Hits New 52-Week Low at $99.73 Amid Financial Struggles

Integer Holdings Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently reached a new 52-week low of USD 99.73 on September 15, 2025. This decline marks a significant downturn for the company, which has experienced a 15.52% decrease in its stock price over the past year, contrasting sharply with the S&P 500's performance of 17.67% during the same period.
The company's market capitalization stands at USD 3,721 million, with a price-to-earnings (P/E) ratio of 45.00. Despite its small size, Integer Holdings Corp. has faced challenges, including a notable drop in net profit, which fell by 81.47% to USD 11.64 million in the first half of 2025 after five consecutive quarters of positive results. Additionally, raw material costs have risen by 11.36% year-over-year, contributing to financial pressures.

With a debt-to-equity ratio of 0.70 and a return on equity of 5.31%, the company is navigating a complex financial landscape. The stock's performance has been below par, with a return of -19.68% over the last year, indicating ongoing difficulties in maintaining growth and profitability.